4-BroMo-1-(phenylsulfonyl)-1H-indazole
97%
- Product Code: 140747
CAS:
1001415-32-2
| Molecular Weight: | 337.192 g./mol | Molecular Formula: | C₁₃H₉BrN₂O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD22566216 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research. It serves in the development of kinase inhibitors and other targeted therapies due to its ability to participate in palladium-catalyzed cross-coupling reactions. Its structure supports the construction of complex indazole-based molecules with potential antitumor, anti-inflammatory, and antimicrobial activities. Commonly employed in medicinal chemistry for scaffold modification and structure-activity relationship (SAR) studies.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1g | 10-20 days | ฿7,400.00 |
+
-
|
4-BroMo-1-(phenylsulfonyl)-1H-indazole
Used as a key intermediate in the synthesis of biologically active compounds, particularly in pharmaceutical research. It serves in the development of kinase inhibitors and other targeted therapies due to its ability to participate in palladium-catalyzed cross-coupling reactions. Its structure supports the construction of complex indazole-based molecules with potential antitumor, anti-inflammatory, and antimicrobial activities. Commonly employed in medicinal chemistry for scaffold modification and structure-activity relationship (SAR) studies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :